tbuckley/cabot-search huggingface dataset:
Abstract 8991: Prognostic Significance of Hyponatremia in Peripartum Cardiomyopathy: Insights from the Peripartum Cardiomyopathy in Nigeria Registry
Authors: Kamilu M Karaye, Naser A Ishaq, Hadiza Saidu, Sulaiman A Balarabe, Umar Gati G Adamu, Idris Y Mohammed, Isa O Oboirien, Ejiroghene Umuerri, Abaram C Mankwe, Vincent Shidali, Sotonye Dodiyi-Manuel, Paschal Njoku, Taiwo T Olunuga, VERONICA JOSEPHS, Okechukwu S Ogah, Amam Mbakwem, Henry Okolie, Mohammed A Talle, Muhammad Sani S Isa
Journal: Circulation (2021)

Introduction: Hyponatraemia is a well-described independent poor prognostic marker for heart failure (HF). However, its prognostic significance in peripartum cardiomyopathy (PPCM) is unknown. Hypothesis: We hypothesized that hyponatremia will have prognostic significance in PPCM patients. Methods: In this post-hoc analysis of PEACE registry results, we aimed to determine the prognostic significance of hyponatremia in PPCM patients. We consecutively recruited the PPCM patients from 14 sites in Nigeria and followed them up for a median of 18 months. Serum sodium was measured at baseline, and patients with hyponatremia (&lt;135mmol/L) were compared with those with normal values. Unrecovered LV systolic function was defined as LVEF ≤55%. Predictors of mortality were determined using a Cox-Proportional Hazard Regression model. Results: Overall, 90 of 191 (47.1%) PPCM patients had hyponatremia at presentation, with a mean serum sodium concentration of 126.7±22.3mmol/L (Table 1). Baseline clinical characteristics and prescriptions for diuretics and other HF drugs were well-balanced between the 2 groups. All-cause mortality among hyponatremic patients (24/90; 26.7%) was significantly higher than among patients with normal serum sodium (7/101; 6.9%) (p-value&lt;0.001). The risk for all-cause mortality was independently increased by hyponatremia (Hazard Ratio: 3.18 [95% CI: 1.35-7.52; p=0.008]), hypotension (systolic BP&lt;100mmHg) (2.22 [1.03-4.79]; p=0.043) and LVEF &lt;25% (3.14[1.47-6.73], p=0.003), after adjusting for loop diuretics, serum creatinine, preeclampsia and tachycardia. Majority of the patients did not recover LV systolic function and rehospitalization was uncommon in both groups. Conclusions: Hyponatremia was common in our cohort of PPCM patients, and associated with 3-fold higher risk for all-cause mortality. It was however not associated with rehospitalization and unrecovered LV systolic function.
Bone Marrow Adipocyte Promotes Epithelial-Mesenchymal-Transition-like Activation in Multiple Myeloma Via CXCL-12/CXCR4 Axis
Authors: Ling-Ling Shu, Shuzhao Chen, Jinyuan Li, Weida Wang, Yang Liu, Yang Li, Han-Ying Huang, Xiaoping Wu, Yang Liang
Journal: Blood (2021)
Final Results of the Fibromet Trial: An Open Label Phase II Study to Evaluate Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients
Authors: Paula De Melo Campos, Katia B Pagnano, Rubia Isler Mancuso, Fernanda Isabel Della Via, Ângela Condotta Tinoco, Guilherme Rossi Assis-Mendonça, Leandro Luiz Lopes Freitas, Fabiola Traina, Sara T Olalla Saad
Journal: Blood (2021)
The IL32/BAFF Axis Supports Prosurvival Dialog in the Lymphoma Ecosystem and Is Disrupted By NIK Inhibition
Authors: Salome Decombis, Antonin Papin, Celine Bellanger, Clara Sortais, Christelle Dousset, Yannick Le Bris, Stephanie Blandin, Philippe Hulin, Benoit Tessoulin, Mathieu Rouel, Steven Le Gouill, Agnes Moreau-Aubry, Catherine Pellat-Deceunynck, David Chiron
Journal: Blood (2021)
Epigenetic Enzyme Mutations in Myeloid Malignancies Are Selected By Chromatin-Remodeling Requirements That Vary By Lineage- and Maturation-Stage
Authors: Sunisa Kongkiatkamon, Xiaorong Gu, Kwok Peng Ng, Simona Pagliuca, Vera Adema, Wencke Walter, Yasunobu Nagata, Cassandra M Kerr, Cassandra M Kerr, Manja Meggendorfer, Hassan Awada, Stephan Hutter, Carmelo Gurnari, Claudia Haferlach, Babal K. Jha, Valeria Visconte, Torsten Haferlach, Jaroslaw P. Maciejewski, Yogenthiran Saunthararajah
Journal: Blood (2021)
Germline Variants Contribute Significantly to the Pathogenesis of Aplastic Anemia in India
Authors: Aruna Barade, Arun Kumar Arunachalam, Deborah Arul, Anu Korula, Anup J Devasia, Fouzia NA, Kavitha M Lakshmi, Aby Abraham, Vikram Mathews, Biju George, Eunice Sindhuvi Edison
Journal: Blood (2021)
Epidemiology of Light-Chain Amyloidosis: A Population-Based Cohort Study in Taiwan
Authors: Hsin-An Hou, Chao-Hsiun Tang, Choo Hua Goh, Sarah Siggins, Shih-Pei Shen, Hong Qiu, Wen-Chien Chou, Yanfang Liu
Journal: Blood (2021)
Duration and Dose of Adjuvant Zoledronic Acid for Treatment of Early Breast Cancer—Reply
Authors: Thomas W. P. Friedl, Wolfgang Janni, Brigitte Rack
Journal: JAMA Oncology (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Are sex disparities in COVID-19 a predictable outcome of failing men’s health provision?
Authors: Tharu Tharakan, Christopher C. Khoo, Aleksander Giwercman, Channa N. Jayasena, Nikolaos Sofikitis, Andrea Salonia, Suks Minhas
Journal: Nature Reviews Urology (2021)

The COVID-19 pandemic, caused by the SARS-CoV-2 coronavirus, has taken a catastrophic toll on society, health-care systems and the economy. Notably, COVID-19 has been shown to be associated with a higher mortality rate in men than in women. This disparity is likely to be a consequence of a failure to invest in men's health, as it has also been established that men have a lower life expectancy and poorer outcomes from non-communicable diseases than women. A variety of biological, social and economic factors have contributed to the sex disparities in mortality from COVID-19. A streamlined men's health programme — with the urologist as the gatekeeper of men's health — is needed to help prevent future tragedies of this nature. COVID-19 has been shown to be associated with a higher mortality rate in men than in women. In this Perspectives article, the authors posit that this disparity is due to a failure to invest in men's health and discuss the biological, social and economic factors that have contributed to the sex disparities in mortality from COVID-19, as well as considering how a streamlined men's health programme with the urologist in a central role could address these issues.
METTL3 Dysregulates RNA Splicing by Translational Control of Splicing Factors via m 6A Modification in CLL
Authors: Yiming Wu, Meiling Jin, Mike Fernandez, Kevyn Hart, Aijun Liao, Stacey M. Fernandes, Tinisha McDonald, Lucy Ghoda, Daniel Roeth, Markus Kalkum, Raju Pillai, Jianjun Chen, Jennifer R Brown, Alexey V. Danilov, Steven T. Rosen, Tanya Siddiqi, Lili Wang
Journal: Blood (2021)
The Outcomes of Systemic Chronic Active EBV Infection Treatment By Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of Japanese Registry Data
Authors: Ayako Arai, Masahide Yamamoto, Maho Sato, Yasushi Onishi, Yoji Sasahara, Hideki Sano, Masayoshi Masuko, Hirohisa Nakamae, Ken-Ichi Matsuoka, Takahide Ara, Kana Washio, Makoto Onizuka, Kenichiro Watanabe, Tsuneaki Hirakawa, Miwako Nishio, Chizuko Sakashita, Tohru Kobayashi, Akihisa Sawada, Tatsuo Ichinohe, Takahiro Fukuda, Yoshiko Hashii, Yoshiko Atsuta
Journal: Blood (2021)
Final Induction Therapy Results of an Open Label Phase II Study Using Inotuzumab Ozogamicin for Induction Therapy, Followed By a Conventional Chemotherapy Based Consolidation and Maintenance Therapy in Patients Aged 56 Years and Older with Acute B-Lymphoblastic Leukemia (INITIAL-1 trial)
Authors: Matthias Stelljes, Nael Alakel, Ralph Wäsch, Sebastian Scholl, Kathrin Nachtkamp, Andreas Rank, Mathias Haenel, Bernd Spriewald, Maher Hanoun, Sonja Martin, Katjana Schwab, Julian Knaden, Julia Marx, Klaus Wethmar, Tim Sauer, Wolfgang E. Berdel, Georg Lenz, Martin Dugas, Nicola Goekbuget, Monika Brueggemann, Simon Raffel
Journal: Blood (2021)
Targeting M2-Tumor Associated Macrophages By Arginase-1 and PD-L1 in Regulating Juvenile Myelomonocytic Leukemia (JMML) Development and Relapse
Authors: Santhosh Kumar Pasupuleti, Baskar Ramdas, Kai Yang, Chujing Zhang, Elliot Stieglitz, Reuben Kapur
Journal: Blood (2021)
A First-in-Class STAT3 Degrader KT-333 in Development for Treatment of Hematologic Cancers
Authors: Phillip CC Liu, Vaishali Dixit, Michele Mayo, Joyoti Dey, Karen Yuan, Rahul Karnik, Dirk Walther, Yatao Shi, Kirti Sharma, Haojing Rong, Bin Yang, Ashwin Gollerkeri, Jared Gollob, Chris DeSavi
Journal: Blood (2021)
Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial
Authors: Chikashi Yoshida, Hiroki Yamaguchi, Noriko Doki, Kazunori Murai, Masaki Iino, Yoshihiro Hatta, Makoto Onizuka, Norio Yokose, Katsumichi Fujimaki, Masao Hagihara, Gaku Oshikawa, Kayoko Murayama, Takashi Kumagai, Shinya Kimura, Hideharu Muto, Kensuke Usuki, Kenji Yokoyama, Koh Yamamoto, Nobuyuki Aotsuka, Kenichi Ishizawa, Naoki Takezako, Takuto Miyagishima, Tadao Ishida, Atsushi Shinagawa, Kentaro Wakasa, Tsuyoshi Nakamaki, Naoto Tomita, Katsutoshi Ozaki, Takayoshi Itoh, Shugo Kowata, Kenji Tajika, Takayuki Fujio, Masahiro Onozawa, Masahide Yamamoto, Takeshi Kondo, Yuho Najima, Noriyoshi Iriyama, Ikuyo Tsutsumi, Koji Oba, Hiroshi Kojima, Hisashi Sakamaki, Koiti Inokuchi
Journal: Blood (2021)
Degradable Hydrogel Adhesives with Enhanced Tissue Adhesion, Superior Self‐Healing, Cytocompatibility, and Antibacterial Property
Authors: Yili Yang, Kai Shi, Keman Yu, Feiyue Xing, Haiwang Lai, Yingshan Zhou, Pu Xiao
Journal: Advanced Healthcare Materials (2021)

Abstract Degradable hydrogel adhesives with multifunctional advantages are promising to be candidates as hemostatic agents, surgical sutures, and wound dressings. In this study, hydrogel adhesives are constructed by catechol‐conjugated gelatin from natural resource, iron ions (Fe 3+ ), and a synthetic polymer. Specifically, the latter is prepared by the radical ring‐opening copolymerization of a cyclic ketene acetal monomer 5,6‐benzo‐2‐methylene‐1,3‐dioxepane and N ‐(2‐ethyl p ‐toluenesulfonate) maleimide. By the incorporation of ester bonds in the backbone and the combination with quaternary ammonium salt pendants in the polymer, it exhibits excellent degradability and antibacterial property. Remarkably, doping the synthetic polymer into the 3,4‐dihydroxyphenylacetic acid‐modified gelatin network forms a semi‐interpenetrating polymer network which can effectively improve the rigidity, tissue adhesion, and antibacterial property of fabricated hydrogel adhesives. Moreover, non‐covalent bonds from coordination interaction between catechol and Fe 3+ contribute to the fast self‐healing of the developed hydrogel adhesives. These hydrogel adhesives with the multiple merits including the degradability, enhanced tissue adhesion, superior self‐healing, good cytocompatibility, and antibacterial property show the great potential to be used as tissue adhesives in biomedical fields.
How to Measure Progress in Addressing Physician Well-being
Authors: Lisa S. Rotenstein, Christine Sinsky, Christine K. Cassel
Journal: JAMA (2021)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Abstract 9457: Safety and Feasibility of a Mixed Reality Head Mounted Display in the Cardiac Catheterization Laboratory
Authors: Johnny Chahine, Stephen George, Jason Bartos, Ganesh Raveendran, Sergey Gurevich
Journal: Circulation (2021)

Introduction: Mixed reality (MR) head-mounted displays (HMDs) have been used in a variety of industrial applications. The safety and feasibility of HMDs in cardiac catheterization laboratories (CCLs) for image and procedure guidance have not been studied. Hypothesis: We assessed the hypothesis that MR HMDs are safe and feasible for procedure guidance in CCLs. Methods: 50 patients undergoing diagnostic coronary angiography and right heart catheterization at the University of Minnesota Medical Center were prospectively enrolled in a single-arm trial using an MR HMD for image and procedure guidance including vascular access, fluoroscopy, telemetry, and vital monitoring. Traditional 2D displays were available as back-up. A CCL specific MR HMD (SG Devices LLC, MN) was used. Pearson’s correlation coefficient was used to assess the relationships between procedural outcomes. Results: A total of 62 procedures were performed (47% coronary angiograms, 90% radial). Median age was 64 (58-69) with 66% males (Table 1). Mean procedure time was 22 min (+/- 12) with a mean fluoroscopy time of 3.2 min (+/- 4.1). Contrast volume used was 59 cc (+/-5). Fluoroscopy time was correlated to procedure time (R=0.54, p&lt;0.001) and contrast volume (R=0.72, p&lt;0.001). There were no complications observed peri-procedurally (bleeding, myocardial infarction, stroke, death). Procedure success was 98% (1 procedure could not be completed due to a battery issue). Conclusion: Dedicated CCL MR HMDs are safe and feasible for invasive diagnostic procedures in the CCL, and may improve procedure time, reduce contrast use, and radiation exposure.
Mortality in Acute Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) Is Unpredictable: Poor Statistical Performance of Mortality Prediction Models
Authors: Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela Presson, Marshall Mazepa, Ming Yeong Lim, United States Thrombotic Microangiopathies Consortium Investigators
Journal: Blood (2021)
Identification of Novel Prognostic Biomarkers DDX11 and CHD1 of Allogeneic Hematopoietic Cell Transplantation Outcomes for Patients with MDS: A CIBMTR Comprehensive Genomic Screening
Authors: Tao Zhang, Paul Auer, Stephen R. Spellman, Caitrin Fretham, Yung-Tsi Bolon, Wael Saber
Journal: Blood (2021)
Deep Immune Profiling in Multiple Myeloma at Diagnosis and Under Lenalidomide Maintenance Therapy
Authors: Raija Helena Silvennoinen, Komal Kumar Javarappa, Sini Luoma, Philipp Sergeev, Tiina J Öhman, Markku Varjosalo, Pekka Anttila, Marjaana Säily, Anu Partanen, Marja Sankelo, Caroline A. Heckman
Journal: Blood (2021)
Modulation of Purinergic Signaling Prior to Transplantation Both in Hematopoietic Stem Progenitor Cells (HSPCs) or Recipient Bone Marrow (BM) Microenvironment - As Novel Strategies to Accelerate and Facilitate HSPCs Homing and Engraftment
Authors: Mateusz Adamiak, Arjun Thapa, Kamila Bujko, Katarzyna Brzeźniakiewicz-Janus, Janina Ratajczak, Magda Kucia, Mariusz Z Ratajczak
Journal: Blood (2021)
Long Term Follow up of the Resort Study (E4402): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Low Tumor Burden Follicular Lymphoma
Authors: Brad S. Kahl, Fangxin Hong, Christopher Peterson, Lode J. Swinnen, Thomas M. Habermann, Stephen J Schuster, Matthias Weiss, Paul A S Fishkin, W. Christopher Ehmann, Timothy S. Fenske, Michael E. Williams
Journal: Blood (2021)
Chimerized Anti-ICOS 314.8 Monoclonal Antibodies Inhibit Tumor Cells and Regulatory T Cells in Patients with Sézary Syndrome
Authors: Florent Amatore, Mathilde Barré, Florence Orlanducci, Marc Lopez, Remy Castellano, Caroline Ram-Wolff, Laurent Gorvel, Armelle Goubard, Caroline Gaudy-Marqueste, Martine Bagot, Armand Bensussan, Emmanuel Delaporte, Daniel Olive
Journal: Blood (2021)
Rusfertide (PTG-300), a Hepcidin Mimetic, Maintains Liver Iron Concentration in the Absence of Phlebotomies in Patients with Hereditary Hemochromatosis
Authors: Kris V Kowdley, Nishit B Modi, Frank Valone, Victor M. Priego, Christopher Ferris, Frank Cole, Suneel K Gupta
Journal: Blood (2021)
Prognostic Factors for Early (&amp;lt;2 years) and Late (&amp;gt;5 years) Relapse in Multiple Myeloma- Pivotal Role of Cytogenetic Changes
Authors: Sarah Goldman-Mazur, Alissa Visram, S Vincent Rajkumar, Prashant Kapoor, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis, Wilson I Gonsalves, Rahma M Warsame, Eli Muchtar, Nelson Leung, Robert A. Kyle, Shaji Kumar
Journal: Blood (2021)
Proteomics and Phospho-Proteomics Reveal Predictive Signatures of Response and Mechanisms of Resistance to Midostaurin Plus Chemotherapy in FLT3 Mutant Positive Acute Myeloid Leukemia
Authors: Luis Miguel Veiga Veiga Nobre, Salvatore Federico Pedicona, Arran Dokal, Andrea Arruda, Ryan Smith, Calum Greenhalgh, Francesca Patella, Pedro Casado-Izquierdo, Bela Wrench, Jane Theaker, Andrew Thompson, Mark D. Minden, John G. Gribben, David James Britton, Pedro Cutillas
Journal: Blood (2021)
Hypofractionated Low-Dose Total Skin Electron Beam Therapy for Primary Cutaneous T-Cell Lymphoma: Analysis of Efficacy and Toxicity
Authors: Sofia F Yi, Akshat M Patel, Syed M Rizvi, Praveen Ramakrishnan Geethakumari, Jennifer L Shah, Neil B Desai, Heather W Goff, Kiran A Kumar
Journal: Blood (2021)
Abstract 13070: The Probiotic Bifidobacterium breve, Bif195, Supports the Defense Against Aspirin-Induced Gastrointestinal Mucosal Damage
Authors: Anders B Damholt, Nina Loen, Sara Engel, Anne Haaber, Anja Wellejus, Filip K Knop
Journal: Circulation (2021)

Introduction: Low-dose aspirin (50-325 mg daily) is widely recommended for the prevention of cardiovascular disease. However, daily use of aspirin is associated with an increased risk of gastrointe...
Utilization and Cost Effectiveness of First-Line Yttrium-90 Ibritumomab Tiuxetan in Low-Grade Follicular and Marginal Zone Lymphomas Compared to Standard of Care Bendamustine Plus Rituximab: A Real-World Experience
Authors: Muhamad Alhaj Moustafa, Bijan J Borah, James P Moriarty, Ruchita Dholakia, Liuyan Jiang, Bradford Hoppe, Jennifer Peterson, James R. Cerhan, Han W. Tun
Journal: Blood (2021)
Selinexor in Combination with Daratumumab-Bortezomib and Dexamethasone for the Treatment of Relapse or Refractory Multiple Myeloma: Initial Results of the Phase 2, Open-Label, Multicenter GEM-Selibordara Study
Authors: Paula Rodríguez-Otero, Veronica Gonzalez De La Calle, Anna Sureda, Felipe De Arriba, Marta Reinoso Segura, Paz Ribas, Ana Pilar Gonzalez, Yolanda Gonzalez-Montes, Albert Oriol, Joaquín Martínez-López, Marta Sonia Gonzalez, Miguel T Hernández, Maialen Sirvent, Joan Bladé Creixenti, Juan Jose Lahuerta, Jesús F. San-Miguel, Maria-Victoria Mateos
Journal: Blood (2021)
Abstract PO-086: Exploring therapeutic strategies against pancreatic ductal adenocarcinoma (PDAC)
Authors: Vasiliki Liaki
Journal: Cancer Research (2021)

Abstract Studies of our group have previously assessed the therapeutic efficacy in a PDAC mouse model of the combined genetic elimination of EGFR and RAF1, two main targets of the KRAS molecular pathway. Specifically, our results illustrated that, PDACs are composed of at least two distinct tumor cell populations based on their response (regression or non-response) to the combined elimination of EGFR and c-Raf both in vivo and in vitro that can be distinguished by a different expression profile (Blasco et al., Cancer Cell, 2019). We have further studied the nature of this heterogeneity that interferes with the efficacy of this therapeutic strategy by OMICs and we have identified targetable molecular pathways as promising therapeutic approaches that we are currently validating. Citation Format: Vasiliki Liaki. Exploring therapeutic strategies against pancreatic ductal adenocarcinoma (PDAC) [abstract]. In: Proceedings of the AACR Virtual Special Conference on Pancreatic Cancer; 2021 Sep 29-30. Philadelphia (PA): AACR; Cancer Res 2021;81(22 Suppl):Abstract nr PO-086.
Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treatment Delivery: A Multicentre International Analysis of 1384 Patients
Authors: Matthew R Wilson, Toby A. Eyre, Amy A Kirkwood, Nicole Wong Doo, Carole Soussain, Sylvain Choquet, Nicolas Martinex-Calle, Gavin Preston, Matthew J Ahearne, Elisabeth Schorb, Marie-Pierre Moles-Moreau, Matthew Ku, Chiara Rusconi, Jahanzaib Khwaja, Mayur Narkhede, Katharine L Lewis, Teresa Calimeri, Eric Durot, Loic Renaud, Andreas Kiesbye Øvlisen, Graham McIlroy, Tim Ebsworth, Johnathon Elliot, Anna Santarsiere, Laure Ricard, Nimish Shah, Qin Liu, Adam Zayac, Francesco Vassallo, Laure Lebras, Louise Roulin, Naelle Lombion, Kate Manos, Ruben Fernandez, Nada Hamad, Alberto Lopez-Garcia, Deirdre O'Mahony, Praveen Gounder, Nathalie Forgeard, Charlotte Lees, Kossi Agbetiafa, Tim Strüßmann, Thura Win Htut, Aline Clavert, Hamish W Scott, Anna Guidetti, Brett R Barlow, Jeffrey Smith, Tarec Christoffer El-Galaly, Chan Yoon Cheah, Andres JM Ferreri, Fiona Miall, Christopher P Fox, Kate Cwynarski, Pamela McKay
Journal: Blood (2021)
Long-Term Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
Authors: Sattva S. Neelapu, Julio C. Chavez, Alison R. Sehgal, Narendranath Epperla, Matthew L. Ulrickson, Emmanuel Bachy, Pashna N. Munshi, Carla Casulo, David G. Maloney, Sven de Vos, Ran Reshef, Lori A. Leslie, Olalekan O. Oluwole, Ibrahim Yakoub-Agha, Rashmi Khanal, Joseph D. Rosenblatt, Marika Sherman, Jinghui Dong, Alessandro Giovanetti, Yin Yang, Christine Lui, Zahid Bashir, A Scott Jung, Caron Jacobson
Journal: Blood (2021)